related investors

Related Sciences (RS) is a data science-driven drug discovery firm and venture creation engine founded in 2019. The company utilizes its proprietary Facets AI platform to systematically identify high-probability drug targets by analyzing millions of target-disease pairs against clinical and genetic evidence. RS operates a unique decentralized R&D model, assembling global teams of academic and industry experts to advance a modality-agnostic pipeline. Through strategic partnerships with organizations like Evotec and Charles River, RS builds and manages a portfolio of programs across oncology, immunology, and neurology, including its lead biotech company, Danger Bio. The firm's approach aims to reduce the high failure rates of traditional drug development by prioritizing targets with the strongest biological validation.